Nurix Therapeutics Inc. (NRIX)
NASDAQ · Healthcare
Nurix Therapeutics Inc. EPS 2019–2025
Nurix Therapeutics Inc. annual/quarterly eps history and growth rate from 2021 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Nurix Therapeutics Inc. eps for the quarter ending February 28, 2026 was $0.79, a 17.91% increase year-over-year.
- Nurix Therapeutics Inc. annual eps for 2025 was $3.05, a 5.90% increase from 2024.
- Nurix Therapeutics Inc. annual eps for 2024 was $2.88, a 8.68% increase from 2023.
- Nurix Therapeutics Inc. annual eps for 2023 was $2.65, a 28.57% decrease from 2022.
- Nurix Therapeutics Inc. annual eps for 2022 was $3.71.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Nurix Therapeutics Inc. EPS — FAQ
Nurix Therapeutics Inc. (NRIX) eps over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Nurix Therapeutics Inc.'s eps?
Nurix Therapeutics Inc. (NRIX) reported eps of $-3.05 for fiscal 2025.
Where can I see NRIX's eps history?
The chart and table above show Nurix Therapeutics Inc.'s eps by year and by quarter, including the growth rate.